| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |